PAK1IP1
Basic information
Region (hg38): 6:10694972-10709782
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PAK1IP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 27 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 27 | 0 | 0 |
Variants in PAK1IP1
This is a list of pathogenic ClinVar variants found in the PAK1IP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-10695001-G-T | not specified | Uncertain significance (Dec 04, 2024) | ||
6-10695041-C-G | not specified | Uncertain significance (Jan 16, 2024) | ||
6-10697331-C-T | not specified | Uncertain significance (Mar 20, 2024) | ||
6-10697347-C-A | not specified | Uncertain significance (Jan 31, 2024) | ||
6-10697351-C-T | not specified | Uncertain significance (Mar 24, 2023) | ||
6-10697355-A-G | not specified | Uncertain significance (Jun 06, 2023) | ||
6-10697397-G-A | not specified | Uncertain significance (May 30, 2023) | ||
6-10697397-G-C | not specified | Uncertain significance (Jul 05, 2023) | ||
6-10697402-G-T | not specified | Uncertain significance (Jul 05, 2023) | ||
6-10697435-A-G | not specified | Uncertain significance (Nov 03, 2023) | ||
6-10697439-A-G | not specified | Uncertain significance (Mar 23, 2022) | ||
6-10697448-A-G | not specified | Uncertain significance (Aug 16, 2022) | ||
6-10702431-C-T | not specified | Uncertain significance (Aug 11, 2024) | ||
6-10702437-T-C | not specified | Uncertain significance (Jan 23, 2025) | ||
6-10702446-G-C | not specified | Uncertain significance (Jan 30, 2024) | ||
6-10702468-T-C | not specified | Uncertain significance (Nov 17, 2022) | ||
6-10702572-G-T | not specified | Uncertain significance (Apr 12, 2024) | ||
6-10702576-C-G | not specified | Uncertain significance (Nov 24, 2024) | ||
6-10702590-C-T | not specified | Uncertain significance (Feb 22, 2025) | ||
6-10702608-G-A | not specified | Uncertain significance (Dec 30, 2023) | ||
6-10702624-C-A | not specified | Uncertain significance (Oct 25, 2024) | ||
6-10703443-A-G | not specified | Uncertain significance (Mar 06, 2023) | ||
6-10704541-G-C | not specified | Uncertain significance (Nov 10, 2024) | ||
6-10704578-T-A | not specified | Uncertain significance (May 20, 2024) | ||
6-10704578-T-C | not specified | Uncertain significance (Aug 11, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PAK1IP1 | protein_coding | protein_coding | ENST00000379568 | 10 | 15088 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.363 | 0.637 | 125729 | 0 | 19 | 125748 | 0.0000756 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.827 | 173 | 206 | 0.838 | 0.00000986 | 2593 |
Missense in Polyphen | 44 | 55.294 | 0.79575 | 702 | ||
Synonymous | 0.179 | 70 | 71.9 | 0.973 | 0.00000363 | 711 |
Loss of Function | 3.02 | 4 | 17.7 | 0.226 | 7.46e-7 | 222 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000431 | 0.000431 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000798 | 0.0000791 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Negatively regulates the PAK1 kinase. PAK1 is a member of the PAK kinase family, which has been shown to play a positive role in the regulation of signaling pathways involving MAPK8 and RELA. PAK1 exists as an inactive homodimer, which is activated by binding of small GTPases such as CDC42 to an N-terminal regulatory domain. PAK1IP1 also binds to the N-terminus of PAK1, and inhibits the specific activation of PAK1 by CDC42. May be involved in ribosomal large subunit assembly (PubMed:24120868). {ECO:0000269|PubMed:11371639, ECO:0000269|PubMed:24120868}.;
- Pathway
- EGF-Ncore
(Consensus)
Recessive Scores
- pRec
- 0.123
Intolerance Scores
- loftool
- 0.567
- rvis_EVS
- 0.15
- rvis_percentile_EVS
- 64.51
Haploinsufficiency Scores
- pHI
- 0.596
- hipred
- Y
- hipred_score
- 0.802
- ghis
- 0.522
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.954
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pak1ip1
- Phenotype
- growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; craniofacial phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; skeleton phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- cell population proliferation;negative regulation of signal transduction;ribosomal large subunit biogenesis;roof of mouth development;regulation of signal transduction by p53 class mediator
- Cellular component
- nucleolus
- Molecular function
- protein binding